SkyAI Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 30

Employees

  • Stock Symbol
  • SKYA

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $2.32
  • (As of Friday Closing)

SkyAI General Information

Description

SkyAI Inc is a digital asset treasury company. It is developing financial technology solutions that combine stablecoin infrastructure and artificial intelligence to provide financial services, educational resources, and financial information to users in Asia, Latin America, and Africa.

Contact Information

Website
www.skyai.co
Formerly Known As
Sharps Technology
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 105 Maxess Road Melville
  • Suite 124
  • New York, NY 11747
  • United States
+1 (631)
Primary Industry
Financial Software
Other Industries
Business/Productivity Software
Stock Exchange
NAS
Corporate Office
  • 105 Maxess Road Melville
  • Suite 124
  • New York, NY 11747
  • United States
+1 (631)

SkyAI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SkyAI Stock Performance

As of 13-Nov-2026, SkyAI’s stock price is $2.32. Its current market cap is $118M with 50.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.32 $2.45 $0.91 - $3.41 $118M 50.9M 1.45M $0.29

SkyAI Financials Summary

As of 30-Sep-2026, SkyAI has a trailing 12-month revenue of $193K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 72,564 55,968 4,076 797
Revenue 193 204 0 0
EBITDA (207,308) (269,786) (3,523) (9,128)
Net Income (207,251) (282,502) (9,296) (9,842)
Total Assets 243,955 269,075 7,314 11,789
Total Debt 260 3,085 3,764 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SkyAI Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SkyAI‘s full profile, request access.

Request a free trial

SkyAI Patents

SkyAI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022165083-A1 Needle and syringe system with automatic safety shield that renders a needle safe Inactive 29-Jan-2021
JP-2022540016-A Self-regulating, ultra-low-waste disposable syringe with integrated safety features Active 27-Jun-2019
JP-2022539092-A Ultra low waste disposable safety syringe for low dose injection Pending 27-Jun-2019
CA-3144276-A1 Ultra-low waste disposable safety syringe for low dose injections Pending 27-Jun-2019
WO-2020264057-A1 Ultra-low waste disposable safety syringe for low dose injections Inactive 27-Jun-2019 A61M5/3134
To view SkyAI’s complete patent history, request access »

SkyAI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SkyAI Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SkyAI‘s full profile, request access.

Request a free trial

SkyAI Investments (2)

SkyAI’s most recent deal was a Corporate Asset Purchase with Nephron Pharmaceuticals (InjectEZ Specialty Copolymer Syringe Manufacturing Facility) for . The deal was made on 26-Sep-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nephron Pharmaceuticals (InjectEZ Specialty Copolymer Syringe Manufacturing Facility) 26-Sep-2023 Corporate Asset Purchase Buildings and Property
Safegard Medical (Syringe Manufacturing Facility in Hungary) 06-Jul-2022 Corporate Asset Purchase Medical Supplies
To view SkyAI’s complete investments history, request access »

SkyAI ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

41.21 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view SkyAI’s complete esg history, request access »

SkyAI FAQs

  • When was SkyAI founded?

    SkyAI was founded in 2017.

  • Where is SkyAI headquartered?

    SkyAI is headquartered in New York, NY.

  • What is the size of SkyAI?

    SkyAI has 30 total employees.

  • What industry is SkyAI in?

    SkyAI’s primary industry is Financial Software.

  • Is SkyAI a private or public company?

    SkyAI is a Public company.

  • What is SkyAI’s stock symbol?

    The ticker symbol for SkyAI is SKYA.

  • What is the current stock price of SkyAI?

    As of 13-Nov-2026 the stock price of SkyAI is $2.32.

  • What is the current market cap of SkyAI?

    The current market capitalization of SkyAI is $118M.

  • What is SkyAI’s current revenue?

    The trailing twelve month revenue for SkyAI is $193K.

  • What is SkyAI’s annual earnings per share (EPS)?

    SkyAI’s EPS for 12 months was $0.29.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process